Cargando…

A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance

Toll-like receptor-4 (TLR4) plays a critical role in innate and acquired immunity, but its role in radio-resistance is unknown. We used TLR4 knockout (KO,(−/−)) mice and gut commensal depletion methods, to test the influence of TLR4 and its' in vivo agonist on basal radio-resistance. We found t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, C, Zhang, C, Mitchel, R EJ, Cui, J, Lin, J, Yang, Y, Liu, X, Cai, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674368/ https://www.ncbi.nlm.nih.gov/pubmed/23722538 http://dx.doi.org/10.1038/cddis.2013.161

Ejemplares similares

A critical role of toll-like receptor 2 (TLR2) and its’ in vivo ligands in radio-resistance
por: Gao, Fu, et al.
Publicado: (2015)

Toll-Like Receptor 4 (TLR4) and Typhoid Fever in Vietnam
por: Hue, Nguyen Thi, et al.
Publicado: (2009)

Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
por: Qureshi, Salman T., et al.
Publicado: (1999)

Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis
por: Smith, Rh. Ll., et al.
Publicado: (2016)

Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4)
por: Smirnova, Irina, et al.
Publicado: (2000)

Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
por: Vaez, Haleh, et al.
Publicado: (2023)

Toll-like receptor 4 (TLR4): new insight immune and aging
por: Kim, Hyo-Jin, et al.
Publicado: (2023)

Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
por: Ma, Yonggang, et al.
Publicado: (2012)

Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease
por: Budulac, Simona E., et al.
Publicado: (2012)

Expression of Toll-Like Receptors (TLR2 and TLR4) in the Eyes of Mice with Disseminated Acanthamoebiasis
por: Kot, Karolina, et al.
Publicado: (2019)

Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases
por: Peng, Shiqiao, et al.
Publicado: (2016)

The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling
por: Cochet, Florent, et al.
Publicado: (2017)

Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation
por: Tam, Janine S. Y., et al.
Publicado: (2021)

Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease
por: Dai, Wenbin, et al.
Publicado: (2022)

Correction: Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
por: Ma, Yonggang, et al.
Publicado: (2012)

Platelet-Derived Toll-Like Receptor 4 (Tlr-4) Is Sufficient to Promote Microvascular Thrombosis in Endotoxemia
por: Stark, Ryan J., et al.
Publicado: (2012)

The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases
por: ten Oever, Jaap, et al.
Publicado: (2014)

Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
por: Chew, Valerie, et al.
Publicado: (2013)

TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
por: Gorecki, Anastazja M., et al.
Publicado: (2021)

Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients
por: Aref, Salah, et al.
Publicado: (2020)

The Fab Fragment of a Humanized Anti-Toll Like Receptor 4 (TLR4) Monoclonal Antibody Reduces the Lipopolysaccharide Response via TLR4 in Mouse Macrophages
por: Cai, Binggang, et al.
Publicado: (2015)

A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses
por: Takahashi, Koichiro, et al.
Publicado: (2007)

Toll-Like Receptor 4 (TLR4) Expression Affects Schwann Cell Behavior in vitro
por: Zhang, Huanhuan, et al.
Publicado: (2018)

FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy
por: Zali, Hakimeh, et al.
Publicado: (2019)

Corrigendum: Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases
por: Peng, Shiqiao, et al.
Publicado: (2017)

Phospholipid flippases attenuate LPS-induced TLR4 signaling by mediating endocytic retrieval of Toll-like receptor 4
por: van der Mark, Vincent A., et al.
Publicado: (2016)

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
por: Dasu, Mohan R., et al.
Publicado: (2010)

Lipid-Mediated Insertion of Toll-Like Receptor (TLR) Ligands for Facile Immune Cell Engineering
por: Zhang, Michael H., et al.
Publicado: (2020)

Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) Inhibitors
por: Neal, Matthew D., et al.
Publicado: (2013)

A new “sweet” ligand for Toll-like receptor 4
por: Deierborg, Tomas, et al.
Publicado: (2015)

Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide
por: Awasthi, Shanjana, et al.
Publicado: (2020)

Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesity
por: Ji, Yewei, et al.
Publicado: (2019)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

Contrasted evolutionary histories of two Toll-like receptors (Tlr4 and Tlr7) in wild rodents (MURINAE)
por: Fornůsková, Alena, et al.
Publicado: (2013)

Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus
por: Hafrén, Lena, et al.
Publicado: (2015)

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)

Association of Toll-like receptors 4 (TLR-4) gene expression and polymorphisms in patients with severe asthma
por: Shukur, Wasan, et al.
Publicado: (2021)

Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery
por: Honegr, Jan, et al.
Publicado: (2018)

Methemoglobin Is an Endogenous Toll-Like Receptor 4 Ligand—Relevance to Subarachnoid Hemorrhage
por: Kwon, Min Seong, et al.
Publicado: (2015)

Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A
por: Lu, Hailing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_652vh9f97ptf89crqc240b6jgv